Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Return on Capital Employed: 2011-2024

Historic Return on Capital Employed for Anika Therapeutics (ANIK) over the last 14 years, with Dec 2024 value amounting to -0.02%.

  • Anika Therapeutics' Return on Capital Employed fell 16.00% to -0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.07%, marking a year-over-year decrease of 16.00%. This contributed to the annual value of -0.02% for FY2024, which is 3.00% down from last year.
  • Latest data reveals that Anika Therapeutics reported Return on Capital Employed of -0.02% as of FY2024, which was down 889.74% from 0.00% recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Return on Capital Employed ranged from a high of 0.01% in FY2022 and a low of -0.09% during FY2020.
  • Over the past 3 years, Anika Therapeutics' median Return on Capital Employed value was 0.00% (recorded in 2023), while the average stood at -0.00%.
  • In the last 5 years, Anika Therapeutics' Return on Capital Employed fell by 21bps in 2020 and then grew by 10bps in 2021.
  • Yearly analysis of 5 years shows Anika Therapeutics' Return on Capital Employed stood at -0.09% in 2020, then rose by 10bps to 0.01% in 2021, then remained steady at 0.01% in 2022, then fell by 1bps to 0.00% in 2023, then dropped by 3bps to -0.02% in 2024.